arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ZeroStack Corp.

ZSTK
$3.92 ▼ -0.16 (-3.92%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
20 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
10
Health
Poor
Bearish
auto_awesome

Analytical Summary

ZeroStack Corp. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth -7.7% ↗
Op. Margin -177.4%
ROIC -150.9% ↗
FCF / Share —
Trailing P/E —
Price / Book 0.7x
FCF Yield —
Debt / Equity 0.17
info Valuation on last close. End-of-day price, Sep 23, 2026.

20-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.66M
↓ -7.7% —
Net Income Profit after all expenses
$-24.61M
↓ -920.5% —
Operating Margin Operating profit as % of sales
-177.4%
↓ -429.6% 0th
Long-Term Debt Long-term obligations
$2.41M
↓ -23.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
2
Returns ↓
4
Financial Health →
21
Cash Quality ↓
25

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 20 quarters